The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Altafluor
Fluorescein Sodium and Benoxinate Hydrochloride · FLUORESCEIN SODIUM 2.5 mg/mL; BENOXINATE HYDROCHLORIDE 4 mg/mL · Solution · Ophthalmic · Altaire Pharmaceuticals Inc.
NDC 59390-0218-05 · 5 mL in 1 BOTTLE, DROPPER · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA208582
- TE code
- —
- Approval date
- Dec 14, 2017
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fluorescein Sodium and Benoxinate Hydrochloride (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Altaire Pharmaceuticals Inc. | FLUORESCEIN SODIUM 2.5 mg/mL; BENOXINATE HYDROCHLORIDE 4 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Altaire Pharmaceuticals Inc. | FLUORESCEIN SODIUM 4 mg/mL; BENOXINATE HYDROCHLORIDE 2.5 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Altaire Pharmaceuticals Inc. | BENOXINATE HYDROCHLORIDE 4 mg/mL; FLUORESCEIN SODIUM 2.5 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Altafluor — NDC 59390-0218-05," retrieved September 3, 2026, https://drugdashboards.com/drug/59390021805.
Free to cite with attribution — see how the data is put together.